The dangers of blue light: what is it and how can we protect against its threat?

A growing body of medical research is beginning to focus on the role played by harmful blue light in damaging the eye, leading to conditions like age-related macular degeneration (AMD).

This has been prompted by two global factors: an ageing population and a younger generation making regular, heavy use of blue light-emitting technology.

In this whitepaper we examine the effects of blue light, the eye’s natural resistance to it, and how that resistance can be bolstered.

Blue light whitepaper download
ophthalmic instruments, glaucoma, macular degeneration

Age-related macular degeneration: the case for early screening

Our whitepaper explores the development of AMD and helps you to understand the key risk factors. Our analysis spans non-modifiable risk factors such as family history and genetic, as well as modifiable factors like smoking, diet and BMI.

Read our paper for insights into:

  • The academic case for targeted screening
  • Lifestyle factors affecting AMD development
  • Understanding wet and dry AMD
  • How ophthalmologists can raise awareness of AMD

The use of MPS II as part of a macular screening programme

Prevention is better than intervention

This whitepaper outlines pragmatic guidelines for a coherent strategy around the prevention and management of age-related macular degeneration (AMD).

  • Written by Dr. Scott Mackie, a Consultant Ophthalmologist.

Contact us today

To enquire about any of our products and services